Photo by jared
The FDA has granted a priority review for Merck & Co's application to expand marketing of its Gardasil HPV vaccine to women aged 27 through 45. [Gardasil is currently approved for currently approved for 9 through 26 yo.]
Expect a decision form the FDA within 6 months.
